Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable N-acetylmuramoyl-L-alanine amidase activity; peptidoglycan binding activity; and peptidoglycan immune receptor activity. Acts upstream of or within several processes, including negative regulation of natural killer cell differentiation involved in immune response; negative regulation of type II interferon production; and regulation of inflammatory response. Predicted to be located in extracellular region and membrane. Is expressed in hemolymphoid system and thymus primordium. Orthologous to human PGLYRP2 (peptidoglycan recognition protein 2).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.